Showing results (861-870 of 1,384) with videos related to

Sort By:
Pageof 139
Clinical Cardiology|November 9, 2005
Prognostic impact of demographic factors and clinical features on the mode of death in high-risk patients after myocardial infarction--a combined analysis from multicenter trialsYee Guan Yap, Trinh Duong, J Martin Bland, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2010
Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled studyUpendram Srinivas-Shankar, Stephen A Roberts, Martin J Connolly, et al.
European Heart Journal|February 7, 2007
Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmiasJeffrey S Healey, Al P Hallstrom, Karl-Heinz Kuck, et al.
European Journal of Applied Physiology|March 21, 2020
Impact of a novel home-based exercise intervention on health indicators in inactive premenopausal women: a 12-week randomised controlled trialLuke J Connolly, Suzanne Scott, Carmelina M Morencos, et al.
The American Journal of Sports Medicine|January 1, 1994
Medial collateral ligament knee sprains in college football. Effectiveness of preventive bracesJ P Albright, J W Powell, W Smith, et al.
Journal of the American College of Cardiology|April 1, 1989
Thermal compression and molding of atherosclerotic vascular tissue with use of radiofrequency energy: implications for radiofrequency balloon angioplastyB I Lee, G J Becker, B F Waller, et al.
Heart Rhythm|August 19, 2014
Prospective long-term evaluation of Optim-insulated (Riata ST Optim and Durata) implantable cardioverter-defibrillator leadsJohn A Cairns, Andrew E Epstein, John Rickard, et al.
Australasian Journal on Ageing|October 29, 2020
An interRAI-derived frailty index is associated with prior hospitalisations in older adults residing in retirement villagesKatherine Bloomfield, Zhenqiang Wu, Annie Tatton, et al.
Thrombosis and Haemostasis|October 4, 2020
Long-Term Treatment with Apixaban in Patients with Atrial Fibrillation: Outcomes during the Open-Label Extension following AVERROESAlexander P Benz, John W Eikelboom, Salim Yusuf, et al.
Heart (British Cardiac Society)|February 19, 2017
Effects of dabigatran according to age in atrial fibrillationMandy N Lauw, John W Eikelboom, Michiel Coppens, et al.
Pageof 139